Company
Novartis
For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Novartis is a publicly traded company operating in the pharmaceutical industry and chemical industry sectors, based in Switzerland. It trades on the Swiss Stock Exchange under the ticker NOVN. Leadership tracked by CEOInsider includes Vasant Narasimhan (CEO).
Leadership
Current
.jpg?width=400){kind=small}
Recent developments
AI summary of recent coverageRecent coverage of Novartis has focused primarily on Chief Executive Vas Narasimhan's appointment to the board of directors at artificial intelligence company Anthropic, which has been characterized as part of a healthcare expansion and potential preparation for an initial public offering. Additional coverage has addressed executive compensation at Novartis, with investor groups criticizing the CEO and management pay as excessive, alongside company strategy discussions regarding acquisitions and operational initiatives including a new manufacturing facility and a stock buyback program.
Summarized from the headlines in the sidebar; see each source for the full story.